"A" is for Avidity
- Author
- Peter L Jones, PhD
- Published
- Mon 13 Feb 2023
- Episode Link
- https://podcasters.spotify.com/pod/show/peter-l-jones/episodes/A-is-for-Avidity-e1urlbr
"Why, sometimes I've believed as many as six impossible things before breakfast." Experimental therapies designed specifically for FSHD are finally arriving for trial in the clinic (i.e., in people). Today we discuss the upcoming Phase 1/2 clinical trial from Avidity using their antibody oligo conjugated siRNA designed specifically to knockdown the DUX4 mRNA in FSHD.
